| __timestamp | Amphastar Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 882000 |
| Thursday, January 1, 2015 | 174172000 | 1361000 |
| Friday, January 1, 2016 | 150976000 | 2058000 |
| Sunday, January 1, 2017 | 149380000 | 3554000 |
| Monday, January 1, 2018 | 187681000 | 5215000 |
| Tuesday, January 1, 2019 | 190434000 | 5504000 |
| Wednesday, January 1, 2020 | 206506000 | 5582000 |
| Friday, January 1, 2021 | 238029000 | 5281000 |
| Saturday, January 1, 2022 | 250127000 | 5385000 |
| Sunday, January 1, 2023 | 293274000 | 6481000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Over the past decade, Amphastar Pharmaceuticals has consistently reported a higher cost of revenue compared to Corcept Therapeutics. From 2014 to 2023, Amphastar's cost of revenue surged by approximately 84%, peaking at nearly $293 million in 2023. In contrast, Corcept's cost of revenue, while significantly lower, increased by over 600% during the same period, reaching around $6.5 million in 2023.
These trends highlight the differing operational scales and strategies of these two companies, offering valuable insights for investors and industry analysts.
Analyzing Cost of Revenue: Johnson & Johnson and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Trends: Sanofi vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Viatris Inc. vs Corcept Therapeutics Incorporated
Intra-Cellular Therapies, Inc. vs Corcept Therapeutics Incorporated: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Corcept Therapeutics Incorporated and Bausch Health Companies Inc.
Comparing Cost of Revenue Efficiency: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Xenon Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
MorphoSys AG vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Amphastar Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Evotec SE